What is the Predictive Value of Preoperative CA 125 Level on the Survival Rate of Type 1 Endometrial Cancer?

Overview

Journal Turk J Med Sci

Specialty General Medicine

Date 2020 Sep 27

PMID 32979897

Citations 3

Authors

Safak Yilmaz Baran

Songul Alemdaroglu

Gulsen Dogan Durdag

Seda Yuksel Simsek

Filiz Bolat

Fatih Kose

Husnu Celik

Affiliations

Soon will be listed here.

Abstract

Background/aim: To investigate the utility of preoperative serum cancer antigen 125 (CA 125) levels in type 1 endometrial carcinoma (EC) as a marker for determining poor prognostic factors and survival.

Material And Methods: All patients with endometrial cancer, who had been treated between 2012 and 2020, were retrospectively reviewed, and finally, 256 patients with type 1 endometrium carcinoma were included in the study. The relationship between the clinicopathological characteristics, CA 125 level, and survival rates were analyzed. The cut-off value for the preoperative serum CA 125 level was defined as 16 IU/L.

Results: The median serum CA 125 levels were significantly higher in patients with deep myometrial invasion, lymph node metastasis, lymphovascular space invasion, cervical stromal and adnexal involvement, advanced stage, positive peritoneal cytology, recurrence, and adjuvant therapy requirement. Serum CA 125 cut-off values determined according to clinicopathologic factors ranged from 15.3 to 22.9 IU/L (sensitivity 61%–77%, specificity 52%–73%). The disease-specific survival rate was significantly higher in patients with CA 125 levels < 16 IU/L (P = 0.047).

Conclusion: The data showed that choosing a lower threshold value for the CA 125 level (16 IU/L) instead of 35 IU/L, could be more useful in type 1 EC patients with negative prognostic factors.

Citing Articles

Preoperative cancer antigen-125 levels as a predictor of recurrence in early-stage endometrial cancer.

Erturk A, Korkmaz E, Arslantas Z, Bekdemir S, Erturk N Rev Assoc Med Bras (1992). 2024; 70(5):e20231115.

PMID: 38775501 PMC: 11110966. DOI: 10.1590/1806-9282.20231115.

Preoperative serum tissue factor pathway inhibitor‑2 level as a prognostic marker for endometrial cancer.

Kawaguchi R, Maehana T, Yamanaka S, Miyake R, Kawahara N, Iwai K Oncol Lett. 2023; 26(5):463.

PMID: 37854864 PMC: 10580007. DOI: 10.3892/ol.2023.14050.

Endometrial thickness and uterine artery Doppler parameters as soft markers for prediction of endometrial cancer in postmenopausal bleeding women: a cross-sectional study at tertiary referral hospitals from Vietnam.

Nguyen P, Nguyen V Obstet Gynecol Sci. 2022; 65(5):430-440.

PMID: 35488358 PMC: 9483670. DOI: 10.5468/ogs.22053.

References

Reijnen C, Visser N, Kasius J, Boll D, Geomini P, Ngo H . Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study. J Gynecol Oncol. 2019; 30(5):e70. PMC: 6658593. DOI: 10.3802/jgo.2019.30.e70. View

Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter M, Ezzati M . Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol. 2017; 6(2):95-104. PMC: 5805864. DOI: 10.1016/S2213-8587(17)30366-2. View

Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J . ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up. Int J Gynecol Cancer. 2015; 26(1):2-30. PMC: 4679344. DOI: 10.1097/IGC.0000000000000609. View

Schmidt M, Segev Y, Sadeh R, Suzan E, Feferkorn I, Kaldawy A . Cancer Antigen 125 Levels are Significantly Associated With Prognostic Parameters in Uterine Papillary Serous Carcinoma. Int J Gynecol Cancer. 2018; 28(7):1311-1317. DOI: 10.1097/IGC.0000000000001300. View

Patsner B, Yim G . Predictive value of preoperative serum CA-125 levels in patients with uterine cancer: The Asian experience 2000 to 2012. Obstet Gynecol Sci. 2013; 56(5):281-8. PMC: 3784131. DOI: 10.5468/ogs.2013.56.5.281. View

Modarres-Gilani M, Vaezi M, Shariat M, Zamani N, Nourizadeh R . The prognostic role of preoperative serum CA125 levels in patients with advanced endometrial carcinoma. Cancer Biomark. 2017; 20(2):135-141. DOI: 10.3233/CBM-160529. View

Nicklin J, Janda M, Gebski V, Jobling T, Land R, Manolitsas T . The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer. Int J Cancer. 2011; 131(4):885-90. DOI: 10.1002/ijc.26433. View

Koper N, Massuger L, Thomas C, Kiemeney L, Verbeek A . Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy. Anticancer Res. 1998; 18(3B):1897-902. View

Pecorelli S . Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009; 105(2):103-4. DOI: 10.1016/j.ijgo.2009.02.012. View

10.

Goksedef B, Gorgen H, Yilmaz Baran S, Api M, Cetin A . Preoperative serum CA 125 level as a predictor for metastasis and survival in endometrioid endometrial cancer. J Obstet Gynaecol Can. 2011; 33(8):844-850. DOI: 10.1016/S1701-2163(16)34988-X. View

11.

Chao A, Tang Y, Lai C, Chang C, Chang S, Wu T . Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer. Gynecol Oncol. 2013; 129(3):500-4. DOI: 10.1016/j.ygyno.2013.02.032. View

12.

Chung H, Kim J, Park N, Song Y, Kang S, Lee H . Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand. 2007; 85(12):1501-5. DOI: 10.1080/00016340601022777. View

13.

Nikolaou M, Kourea H, Tzelepi V, Adonakis G, Scopa C, Tsapanos V . The prognostic role of preoperative serum CA 125 levels in patients with endometrial carcinoma. J BUON. 2014; 19(1):198-202. View

14.

Soper J, Berchuck A, Olt G, Soisson A, Clarke-Pearson D, Bast Jr R . Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma. Am J Obstet Gynecol. 1990; 163(4 Pt 1):1204-9. DOI: 10.1016/0002-9378(90)90692-z. View

15.

Jiang T, Huang L, Zhang S . Preoperative serum CA125: a useful marker for surgical management of endometrial cancer. BMC Cancer. 2015; 15:396. PMC: 4438478. DOI: 10.1186/s12885-015-1260-7. View

16.

Mariani A, Webb M, Keeney G, Haddock M, Calori G, Podratz K . Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?. Am J Obstet Gynecol. 2000; 182(6):1506-19. DOI: 10.1067/mob.2000.107335. View

17.

Atguden Z, Yildiz A, Aksut H, Yalcin S, Yalcin Y, Uysal D . The Value of Preoperative CA 125 Levels in Prediction of Myometrial Invasion in Patients with Early-stage Endometrioid- type Endometrial Cancer. Asian Pac J Cancer Prev. 2016; 17(2):497-501. DOI: 10.7314/apjcp.2016.17.2.497. View

18.

Ebina Y, Sakuragi N, Hareyama H, Todo Y, Nomura E, Takeda M . Para-aortic lymph node metastasis in relation to serum CA 125 levels and nuclear grade in endometrial carcinoma. Acta Obstet Gynecol Scand. 2002; 81(5):458-65. DOI: 10.1034/j.1600-0412.2002.810514.x. View

19.

Duk J, Aalders J, Fleuren G, de Bruijn H . CA 125: a useful marker in endometrial carcinoma. Am J Obstet Gynecol. 1986; 155(5):1097-102. DOI: 10.1016/0002-9378(86)90358-3. View

20.

Miller K, Nogueira L, Mariotto A, Rowland J, Yabroff K, Alfano C . Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019; 69(5):363-385. DOI: 10.3322/caac.21565. View